Molecular pathogenesis of alcohol-induced hepatic fibrosis.
about
Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticlesEffect of ginseng extract on the TGF-β1 signaling pathway in CCl4-induced liver fibrosis in ratsGinseng extract and ginsenoside Rb1 attenuate carbon tetrachloride-induced liver fibrosis in ratsAntioxidative status of patients with alcoholic liver disease in southeastern Taiwan.Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosisImmunological response in alcoholic liver disease.Chronic alcohol exposure alters gene expression in HepG2 cells.Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defenceProtective effect of sodium ferulate on acetaldehyde-treated precision-cut rat liver slices.The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism.Effect of ethanol on inflammatory responses. Implications for pancreatitis.Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex.Systems genetics of hepatocellular damage in vivo and in vitro: identification of a critical network on chromosome 11 in mouse.Pathogenesis of alcoholic liver disease: interactions between parenchymal and non-parenchymal cells.Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis.Current experimental perspectives on the clinical progression of alcoholic liver disease.Venlafaxine-Induced Cytotoxicity Towards Isolated Rat Hepatocytes Involves Oxidative Stress and Mitochondrial/Lysosomal Dysfunction.PCBP2 siRNA reverses the alcohol-induced pro-fibrogenic effects in hepatic stellate cells.Role of the endocannabinoid system in alcoholic liver disease.Role of oxidative stress in the pathogenesis of alcohol-induced liver disease.Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention.Metabolic zonation of the liver: The oxygen gradient revisited.In vivo measurement of aldehyde dehydrogenase-2 activity in rat liver ethanol model using dynamic MRSI of hyperpolarized [1-(13) C]pyruvate.Antifibrotic activity of hesperidin against dimethylnitrosamine-induced liver fibrosis in rats.Carvedilol attenuates the progression of alcohol fatty liver disease in rats.Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.Pathological roles of bone marrow-derived stellate cells in a mouse model of alcohol-induced fatty liver.MMP-2 and MMP-9 activities and TIMP-1 and TIMP-2 expression in the prostatic tissue of two ethanol-preferring rat models.
P2860
Q26769611-6ABFD752-F314-4DB1-80BD-149CDBC58546Q28075551-CB36DFAA-8A24-4622-AFA5-502655790484Q28468606-F85FD860-5961-410E-AA48-BF6ADDF9617EQ34438937-93F82490-835A-4CCA-8F72-E2632ED1D7FDQ34670902-99DD8129-8C17-4668-BFD9-3C3D69BC6ED0Q34853017-7A286869-BA09-4D3F-B41C-B7CE84ACD12FQ35615727-6D75BAB2-1CF6-424D-A5EB-FFD77EFF468DQ35911488-F7CCB4C4-D1FC-4CFD-85A0-C11FE5D9CFD3Q35940373-3ED4F66D-0F14-4D8F-BB76-19D11EBAA711Q35986186-20CC8B7F-2B43-42A1-9DA2-C0B31AF885D2Q35989527-B7797D40-CC64-45DE-AAE1-130F0EF928E8Q36860404-CFE3343A-F6FD-4CEE-9E52-577BF18DE45FQ37108904-F5E8EBB9-03C6-4DCB-B331-AF250E60BC06Q37234865-D2E5D53E-3030-461E-B882-511F81A120B4Q37334084-34497518-748B-4A58-B49C-E02129EBC4CDQ37426714-6D397585-6322-4B39-925A-4265FD4B2C88Q37567924-7447D108-66C4-4AEA-B042-33238B213664Q37590725-093C1F86-6C61-411E-BAE8-E35CDCBD6610Q37675646-7BBDC01D-ED48-402B-9BBA-4F9A48B43229Q37869767-3007798D-7533-4EFF-9671-DB152D5582F3Q38116979-E821A422-8B6A-4C51-9AFE-D3AE3758C33BQ38879747-BD96D648-7082-49F6-BBA0-63A704351AADQ39105478-9595646D-1F76-410F-9680-194CA9F03990Q40061629-41562333-7887-43E6-AC0D-66E3B0E9295EQ42231633-33BFB401-0B81-4F08-B8A8-4613179F7712Q42720548-1753AEA8-B1D4-4A1B-A18B-FCFE44902ACDQ44574643-E437CC21-5F68-47F2-B131-4E657FCCE268Q45927487-8261DB09-46FD-4FE4-9076-8BFE0148E52AQ54911489-274F9A1E-1755-4851-92AB-419B70180510
P2860
Molecular pathogenesis of alcohol-induced hepatic fibrosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Molecular pathogenesis of alcohol-induced hepatic fibrosis.
@ast
Molecular pathogenesis of alcohol-induced hepatic fibrosis.
@en
type
label
Molecular pathogenesis of alcohol-induced hepatic fibrosis.
@ast
Molecular pathogenesis of alcohol-induced hepatic fibrosis.
@en
prefLabel
Molecular pathogenesis of alcohol-induced hepatic fibrosis.
@ast
Molecular pathogenesis of alcohol-induced hepatic fibrosis.
@en
P2860
P1476
Molecular pathogenesis of alcohol-induced hepatic fibrosis.
@en
P2093
Sören V Siegmund
P2860
P304
P356
10.1097/01.ALC.0000189275.97419.58
P433
P577
2005-11-01T00:00:00Z